SCHEMBL1765856

SCHEMBL1765856

Nc1cccc2ccnnc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.39
LMNA P02545 4/20 0.39
CYP2D6 P10635 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
TSHR P16473 4/20 0.38
ALDH1A1 P00352 4/20 0.38
HSD17B10 Q99714 3/20 0.38
HPGD P15428 3/20 0.38
KEAP1 Q14145 1/20 0.38
HTR3A P46098 1/20 0.38
KDM4E B2RXH2 4/20 0.36
MAPT P10636 3/20 0.36
HIF1A Q16665 2/20 0.36
TDP1 Q9NUW8 5/20 0.36
BACE1 P56817 2/20 0.35
PLAU P00749 2/20 0.35
NCF1 P14598 2/20 0.35
MMP2 P08253 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3074924 0.77 TSHR (0.42) CYP3A4LMNACYP2D6TSHRALDH1A1
SCHEMBL2008753 0.74 KDM4E (0.39) CYP3A4LMNACYP2D6CYP1A2TSHR
SCHEMBL10841983 0.74 MEN1 (0.39) CYP3A4LMNACYP2D6CYP1A2TSHR
SCHEMBL277448 0.74 KDM4E (0.34) CYP3A4LMNACYP2D6TSHRALDH1A1
SCHEMBL19001485 0.74 MMP2 (0.34) CYP3A4LMNACYP2D6TSHRKDM4E
SCHEMBL3886362 0.74 MMP2 (0.34) CYP3A4LMNACYP2D6TSHRALDH1A1
SCHEMBL12737722 0.74 BACE1 (0.48) CYP3A4LMNACYP2D6CYP1A2CYP2C9
SCHEMBL19055257 0.74 PSMD14 (0.57) CYP3A4LMNACYP2D6TSHRKDM4E
SCHEMBL3887261 0.74 LMNA (0.38) CYP3A4LMNACYP2D6TSHRALDH1A1
SCHEMBL277449 0.74 METAP2 (0.57) CYP3A4LMNACYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3185330-B1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO LTD (KR) 2023-08-16 EP disclosed
EP-3246963-B1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO LTD (KR) 2023-05-31 EP disclosed
EP-3822258-B1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THIN FILM FORMED FROM THE COMPOSITION SAMSUNG DISPLAY CO LTD (KR) 2022-06-15 EP disclosed
US-20220046923-A1 HERBICIDAL CINNOLINIUM COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2022-02-17 US disclosed
EP-3898594-A1 HERBICIDAL CINNOLINIUM COMPOUNDS Syngenta Crop Protection AG (CH) 2021-10-27 EP disclosed
EP-3244466-B1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO LTD (KR) 2021-08-04 EP disclosed
CN-113195455-A Herbicidal cinnolinium compounds 先正达农作物保护股份公司 2021-07-30 CN disclosed
EP-3822258-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THIN FILM FORMED FROM THE COMPOSITION Samsung Display Co., Ltd. (KR) 2021-05-19 EP disclosed
EP-3693372-A1 BENZOFURO[3',2':4,5]IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN ORGANIC LIGHT-EMITTING DEVICES (OLEDS) Samsung Display Co., Ltd. (KR) 2020-08-12 EP disclosed
WO-2020127168-A1 HERBICIDAL CINNOLINIUM COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2020-06-25 WO disclosed
EP-2003135-A2 PROCESS FOR PRODUCING OPTICALLY ACTIVE CHROMENE OXIDE COMPOUND Nissan Chemical Industries, Ltd. (JP) 2008-12-17 EP disclosed
US-20080004262-A1 Tricyclic Benzopyrane Compound as Anti-Arrhythmic Agents NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2008-01-03 US disclosed
EP-1732929-A1 TRICYCLIC BENZOPYRAN COMPOUND AS ANTI-ARRHYTHMIC AGENTS Nissan Chemical Industries, Ltd. (JP) 2006-12-20 EP disclosed
WO-2005090357-A1 TRICYCLIC BENZOPYRAN COMPOUND AS ANTI-ARRHYTHMIC AGENTS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2005-09-29 WO disclosed
EP-0944600-B1 PROCESS FOR CONVERTING HYDROXY HETEROAROMATICS TO ARYLAMINES AVENTIS PHARMA INC (US) 2002-01-30 EP disclosed
US-6034241-A Process for converting hydroxy heteroaromatics to arylamines HOECHST MARION ROUSSEL INC. (US) 2000-03-07 US disclosed
EP-0944600-A1 PROCESS FOR CONVERTING HYDROXY HETEROAROMATICS TO ARYLAMINES HOECHST MARION ROUSSEL, INC. (US) 1999-09-29 EP disclosed
EP-0866692-A1 USE OF BICYCLIC MONO- OR DIKETONE DERIVATIVES, RESULTING COMPOUNDS, AND USE THEREOF AS A DRUG FOR TREATING INFLAMMATION, MIGRAINE AND SHOCK LABORATOIRE INNOTHERA Société Anonyme (FR) 1998-09-30 EP disclosed
WO-1998023589-A1 PROCESS FOR CONVERTING HYDROXY HETEROAROMATICS TO ARYLAMINES HOECHST MARION ROUSSEL, INC. (US) 1998-06-04 WO disclosed
WO-1997021432-A1 USE OF BICYCLIC MONO- OR DIKETONE DERIVATIVES, RESULTING COMPOUNDS, AND USE THEREOF AS A DRUG FOR TREATING INFLAMMATION, MIGRAINE AND SHOCK LABORATOIRE INNOTHERA, S.A. (FR) 1997-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220046923-A1 HERBICIDAL CINNOLINIUM COMPOUNDS DDT, DERL1, CES2 CYP3A4 394/4885LMNA 3770/4885CYP2D6 92/4885
US-20080004262-A1 Tricyclic Benzopyrane Compound as Anti-Arrhythmic Agents CBR1, CBR3, SCN8A CYP3A4 201/4885LMNA 2770/4885CYP2D6 60/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.